Pharmafocus publish article “The global rise in antibiotic resistance threatens infection prevention and cure”

“Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic stewardship required to offset this global threat, and the additional incentivisation initiatives needed to promote innovation, as well as the role of preventative antimicrobial treatments as an important element of this global fight”

Please click on link below for full Pharmafocus article:-

The global rise in antibiotic resistance threatens infection prevention and cure